Home | Clinical Trials on Alzheimer’s Disease

CTAD Educational &

Research Platform

A year-round learning experience to keep you at the forefront of Alzheimer’s research.

Our next event:

19^th Clinical Trials on Alzheimer's Disease (CTAD)

November 16-19, 2026
Boston, MA (United States)

CTAD26 — Call for Abstracts

Be part of the program by submiting before june 2nd!

Submit online

CTAD26 — Hotel List

The CTAD Conference venue is sold out at this time please find here alternative hotels.

Hotel List

CTAD26 — Registrations

Join the CTAD 2026 Congress — Register Now

More info

CTAD Educational & Research Platform

More info

CTAD 2026 Lifetime Achievement Award

This year, the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research is awarded to Jeffrey Cummings, MD, in recognition of his foundational contributions to clinical trial methodology, drug development frameworks, and his decades of leadership in advancing the field through the annual Alzheimer's disease drug development pipeline analyses. Read more.

Important Dates

April

Call for Abstracts: Opening of the online Submission system

July

Late Call for Abstracts: Opening of the Online submission system

April

Registrations open

Sept.

Late Call for Abstracts DEADLINE

June

Call for Abstracts DEADLINE

October

End of the Early Bird rate

The Conference

The Clinical Trials on Alzheimer’s Disease (CTAD) Conference, established in 2008, has become a cornerstone event in Alzheimer’s disease (AD) clinical research. Designed by and for AD researchers, CTAD’s mission is to create a platform that prioritizes substantive, clinical research-focused dialogue and collaboration. By fostering an intimate and collegial environment, CTAD has gained a reputation for facilitating impactful international collaborations and advancing the global AD research agenda.
Read more